About a-team Marketing Services
The knowledge platform for the financial technology industry

A-Team Insight Blogs

Nice Actimize Builds out X-Sight Marketplace with Acuris Addition

Subscribe to our newsletter

Financial crime specialist Nice Actimize has added anti-money laundering and data intelligence capabilities to its financial crime and compliance ecosystem through two new partnerships. Acuris Risk Intelligence and Sayari Labs will provide customised solutions for X-Sight Marketplace, a platform connecting financial services organizations with data, applications, tools and service providers.

“Change in financial crime has been both constant and rapid, and the industry has clearly demonstrated its need for immediate access to advanced financial crime-solving solutions, particularly in fraud and anti-money laundering,” says Craig Costigan, CEO of NICE Actimize.

Acuris Risk Intelligence, which specialises in data intelligence for anti-money laundering, anti-corruption and cybersecurity, offers proprietary data on PEPs, sanctions and AML data for due diligence and compliance, as well as AMl and KYC due diligence and monitoring. Its extensive data set, which also includes fraud and cybersecurity content, can be accessed either through an SaaS platform or via API and feed technology.

On the analytics side, Sayari Labs specialises in beneficial ownership and financial intelligence in emerging, frontier, and offshore jurisdictions. Its Graph function is the first purpose-built platform to illustrate global commercial relationships, providing a holistic picture of customers, vendors, and third parties, as well as detailing provenance back to primary source documents. It uses network visualizations powered by custom graph-based matching and entity resolution models, delivered as a multi-tenant cloud application with an intuitive user interface, REST API, data feeds, and on-prem deployment models.

“Time and accuracy are critical components particularly in AML and financial crime, and our intelligence solutions are designed to quickly provide insights in opaque and hard target countries where securing data is often difficult or nearly impossible,” comments Sayari COO Benjamin Power. “We look forward to developing relationships with customers in the NICE Actimize X-Sight Marketplace who would benefit from our ability to provide swift and accurate identity intelligence.”

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: Client onboarding and KYC: the data management challenges

Client onboarding and Know Your Customer (KYC) processes are imperative to regulatory compliance and building competitive advantage, but how much progress is the industry making in transitioning onboarding from a disjointed process run across many functions to an holistic operation spanning the enterprise? New approaches and technologies are available, so how best can you implement...

BLOG

Asian KYB Requires Live Registry Data, Not Another Database: AsiaVerify CEO

Asian know-your-business (KYB) controls have an uncomfortable blind spot: firms can spend heavily on onboarding, sanctions screening and case management while still making decisions from corporate records that may be weeks or months out of date – and sometimes more. AsiaVerify CEO Leas Bachatene spoke with RegTech Insight about the KYB challenges for firms with...

EVENT

TradingTech Summit London

Now in its 15th year the TradingTech Summit London brings together the European trading technology capital markets industry and examines the latest changes and innovations in trading technology and explores how technology is being deployed to create an edge in sell side and buy side capital markets financial institutions.

GUIDE

Alternative Trading Systems Directory 2010

The year since we launched our first edition of the A-Team Alternative Trading Directory has passed by in a flash (no pun intended). And while the rate of expansion of the alternative trading system sector may have slowed – even consolidated somewhat – in the more established centres, their onward march continues both in terms of credibility, and of uptake...